Myxovirus therapeutics, compounds, and uses related thereto
US9676727B2 · kind B2 · utility
0Cited by
2References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 7, 2016 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Jul 7, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to antiviral compounds disclosed herein and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions. Typically, the pharmaceutical composition comprises a compound of formula I:or salt, prodrug, or ester thereof wherein X, Y, and R1 and R10 to R13 are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.